Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
37%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
CANC
54
HOLDINGS
25%
ALSO IN HRTS
HRTS
42
HOLDINGS
34%
ALSO IN CANC
SECTOR DRIFT (CANC minus HRTS)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
ASTRAZENECA PLC | 4.6% | 4.8% | 4.6% |
 |
ELI LILLY & CO | 4.3% | 10.0% | 4.3% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.1% | 5.5% | 4.1% |
|
MERCK & CO. INC. | 3.8% | 4.2% | 3.8% |
|
NOVARTIS AG | 4.9% | 3.6% | 3.6% |
CANC Overweight Relative to HRTS
|
REVOLUTION MEDICINES, INC. | 4.1% |
|
ARCELLX, INC. | 3.4% |
|
COGENT BIOSCIENCES INC | 3.3% |
|
NUVALENT, INC. CLASS A | 3.1% |
 |
GENMAB A/S SPONSORED ADR | 3.1% |
|
IMMUNOME, INC. | 2.7% |
|
BRIDGEBIO PHARMA, INC. | 2.5% |
|
CELCUITY INC. | 2.5% |
|
EXELIXIS INC | 2.2% |
|
BRISTOL-MYERS SQUIBB CO | 2.1% |
CANC Underweight Relative to HRTS
|
ELI LILLY & CO | -5.7% |
|
THERMO FISHER SCIENTIFIC INC | -4.0% |
|
UNITEDHEALTH GROUP INC | -3.8% |
|
ABBOTT LABORATORIES | -3.4% |
|
VERTEX PHARMACEUTICALS INC | -3.2% |
|
DANAHER CORP | -2.9% |
|
GILEAD SCIENCES INC | -2.8% |
|
BOSTON SCIENTIFIC CORP | -2.5% |
 |
MEDTRONIC PLC | -2.4% |
|
JOHNSON & JOHNSON | -2.3% |